Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Modern Rheumatology · 2024
DOI: 10.1093/mr/roae026 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Takahiko Sugihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Practice Guidelines as Topic, Rheumatology. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To update an evidence base informing the 2024 Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis (RA) in older adults.
Methods
Four clinical questions (CQs) regarding efficacy and safety of drug treatment were evaluated, with CQ1 addressing methotrexate (MTX), CQ2 biological disease-modifying antirheumatic drugs, CQ3 Janus kinase (JAK) inhibitors, and CQ4 glucocorticoids (GCs). Quality of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation system.
Results
Observational studies confirmed a pivotal role of methotrexate in the treatment of older RA patients. The meta-analysis showed that tumour necrosis factor inhibitors and JAK inhibitors were unequivocally effective in older RA patients. No data indicated that biological disease-modifying antirheumatic drugs were unsafe for older patients. No safety data for JAK inhibitor use in older patients were available. One randomized controlled trial demonstrated that long-term treatment with low-dose GCs increased risks of GC-associated adverse events. The certainty of overall evidence was very low for all CQs.
Conclusions
This systematic review provides the necessary evidence for developing 2024 Japan College of Rheumatology clinical practice guidelines for managing older patients with RA. Continued updates on the evidence of JAK inhibitors and GC are desired.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
- Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
- Nagoya City University, Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
ORCID-Profile: Takahiko Sugihara
Zitieren
APA
Sugihara, T., Kawahito, Y., Kaneko, Y., Tanaka, E., Yanai, R., Yajima, N., Kojima, M., & Harigai, M. (2024). Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae026
Vancouver
Sugihara T, Kawahito Y, Kaneko Y, Tanaka E, Yanai R, Yajima N, et al. Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern Rheumatology. 2024. doi:10.1093/mr/roae026
BibTeX
@article{Sugihara2024,
author = {Sugihara, Takahiko and Kawahito, Yutaka and Kaneko, Yuko and Tanaka, Eiichi and Yanai, Ryo and Yajima, Nobuyuki and Kojima, Masayo and Harigai, Masayoshi},
title = {Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis},
journal = {Modern Rheumatology},
year = {2024},
doi = {10.1093/mr/roae026}
}
EUVIMED